FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Autor: Jan Pruim, Eric P. Visser, Arturo Chiti, Klaus Tatsch, Joerg Kotzerke, Ronald Boellaard, Bertjan Arends, Giorgio Testanera, Antoon T.M. Willemsen, Wolfgang A. Weber, Otto S. Hoekstra, Roberto Delgado-Bolton, Lucy Pike, Sigrid Stroobants, Bernd J. Krause, Dominique Delbeke, Scott Holbrook, Andreas Bockisch, Sally F. Barrington, Thomas Beyer, Francesco Giammarile, Michael M. Graham, Josée M. Zijlstra, Fred J. Verzijlbergen, Kevin J. Donohoe, W. Eschner, Corneline J. Hoekstra, Wim J.G. Oyen
Přispěvatelé: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Molecular Neuroscience and Ageing Research (MOLAR), ​Basic and Translational Research and Imaging Methodology Development in Groningen (BRIDGE), Radiology and nuclear medicine, Hematology, CCA - Disease profiling, Radiology & Nuclear Medicine, BV's
Rok vydání: 2015
Předmět:
MULTICENTER TRIALS
medicine.medical_specialty
STANDARDIZED UPTAKE VALUE
Imaging biomarker
FDG
PET/CT
CELL LUNG-CANCER
UPTAKE VALUES
Medizin
Standardized uptake value
Guidelines
Rare cancers Radboud Institute for Molecular Life Sciences [Radboudumc 9]
Multimodal Imaging
POSITRON-EMISSION-TOMOGRAPHY
Fluorodeoxyglucose F18
Neoplasms
Imaging procedure
Quantification
1ST INTERNATIONAL WORKSHOP
Medicine
Humans
Radiology
Nuclear Medicine and imaging
Medical physics
F-18-FDG PET
Computer. Automation
Reproducibility
PET-CT
medicine.diagnostic_test
business.industry
General Medicine
Repeatability
UNKNOWN PRIMARY TUMORS
ROI DEFINITION
Oncology
Radiology Nuclear Medicine and imaging
Positron emission tomography
Positron-Emission Tomography
VOLUME MEASUREMENTS
Tomography
Radiology
Human medicine
Radiopharmaceuticals
Tumour
business
Tomography
X-Ray Computed
Quality assurance
Zdroj: European Journal of Nuclear Medicine and Molecular Imaging, 2, pp. 328-354
European journal of nuclear medicine and molecular imaging
European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 328-354. SPRINGER
European Journal of Nuclear Medicine and Molecular Imaging, 328-354
STARTPAGE=328;ENDPAGE=354;ISSN=1619-7070;TITLE=European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 328-354. Springer Verlag
Boellaard, R, Delgado-Bolton, R, Oyen, W J G, Giammarile, F, Tatsch, K, Eschner, W, Verzijlbergen, F J, Barrington, S F, Pike, L C, Weber, W A, Stroobants, S, Delbeke, D, Donohoe, K J, Holbrook, S, Graham, M M, Testanera, G, Hoekstra, O S, Zijlstra, J M, Visser, E, Hoekstra, C J, Pruim, J, Willemsen, A, Arends, B, Kotzerke, J, Bockisch, A, Beyer, T, Chiti, A & Krause, B J 2015, ' FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 2, pp. 328-354 . https://doi.org/10.1007/s00259-014-2961-x
European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 328-354. Springer-Verlag
ISSN: 1619-7070
DOI: 10.1007/s00259-014-2961-x
Popis: The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET is a quantitative imaging technique and therefore requires a common quality control (QC)/quality assurance (QA) procedure to maintain the accuracy and precision of quantitation. Repeatability and reproducibility are two essential requirements for any quantitative measurement and/or imaging biomarker. Repeatability relates to the uncertainty in obtaining the same result in the same patient when he or she is examined more than once on the same system. However, imaging biomarkers should also have adequate reproducibility, i.e. the ability to yield the same result in the same patient when that patient is examined on different systems and at different imaging sites. Adequate repeatability and reproducibility are essential for the clinical management of patients and the use of FDG PET/CT within multicentre trials. A common standardised imaging procedure will help promote the appropriate use of FDG PET/CT imaging and increase the value of publications and, therefore, their contribution to evidence-based medicine. Moreover, consistency in numerical values between platforms and institutes that acquire the data will potentially enhance the role of semiquantitative and quantitative image interpretation. Precision and accuracy are additionally important as FDG PET/CT is used to evaluate tumour response as well as for diagnosis, prognosis and staging. Therefore both the previous and these new guidelines specifically aim to achieve standardised uptake value harmonisation in multicentre settings.
Databáze: OpenAIRE
Externí odkaz: